Christopher Mast
- Role
- Vice President, Safety Epidemiology and Benefit Risk at Novavax
- Location
- Chapel Hill, NC, US
- LinkedIn followers
- 500 followers
About Christopher Mast
Over 20 years of experience in leading high-impact pharmaceutical vaccine and drug…
Experience
Vice President, Safety Epidemiology and Benefit Risk
Nov 2021 — Present
Built and now lead the safety epidemiology group to support the COVID-19 and other vaccine programs. Our team leads a number of studies and works cross-functionally to develop evidence that supports the post-licensure environment of the COVID-19 vaccine program.
Skills
- Therapeutic Areas
- Microbiology
- Clinical Development
- Virology
- Strategic Planning
- Glp
- Molecular Biology
- Elisa
- Oncology
- Pharmaceutical Industry
- Management
- Epidemiology
- Science
- Clinical Trials
- Drug Development
- Biostatistics
- Immunology
- Clinical Research
- Lifesciences
- Pharmacoepidemiology
- Post Market Surveillance
- Life Sciences
- Cancer
- Cell Culture
- Infectious Diseases
- Vaccines
- Medical Affairs
- Biopharmaceuticals
- Biotechnology
- Outcomes Research
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.